OZEM vs. CANC ETF Comparison
Comparison of Roundhill GLP-1 & Weight Loss ETF (OZEM) to Tema Oncology ETF (CANC)
OZEM
Roundhill GLP-1 & Weight Loss ETF
OZEM Description
OZEM targets the global weight management industry. The fund invests in companies involved in the development of GLP-1 and other weight loss drugs. GLP-1 agonists seek to aid in weight management by lowering blood sugar levels, reducing appetite, and promoting fullness. The portfolio consists of firms with GLP-1 and weight loss drugs that have been approved by or are currently undergoing Phase I, Phase II, and/or Phase III clinical trials of the US Food & Drug Administration (FDA), or any applicable food and drug regulator for non-US companies. The portfolio is constructed using a proprietary methodology, which selects companies with high levels of thematic relevance based on research of each companys public filings and disclosures. In addition, eligible securities must meet minimum market-cap and liquidity requirements. The actively managed fund, although rebalances portfolio weighting on at least a quarterly basis, may have a heavy concentration on a few names.
Grade (RS Rating)
Last Trade
$27.39
Average Daily Volume
28,293
6
CANC
Tema Oncology ETF
CANC Description
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.Grade (RS Rating)
Last Trade
$28.15
Average Daily Volume
4,397
7
Performance
| Period | OZEM | CANC |
|---|---|---|
| 30 Days | -5.04% | -5.76% |
| 60 Days | 3.30% | -0.49% |
| 90 Days | 3.26% | 5.23% |
| 12 Months | 24.00% |
1 Overlapping Holdings
| Symbol | Grade | Weight in OZEM | Weight in CANC | Overlap | |
|---|---|---|---|---|---|
| AMGN | D | 3.27% | 3.78% | 3.27% |
OZEM: Top Represented Industries & Keywords
CANC: Top Represented Industries & Keywords
Compare ETFs
